Cardiometabolic - HUNT MCE

Cardiometabolic Diseases

Cardiometabolic Diseases

For our studies on cardiometabolic diseases, we leverage the genetic and phenotypic data in HUNT linked with electronic health record data and national registries.

Cardiometabolic Diseases

We:

  • examine the genetic determinants of cardiovascular diseases such as coronary heart disease and atrial fibrillation
  • examine genetic determinants of risk factors for cardiovascular diseases, such as serum lipids and chronic kidney disease
  • use genetic variants as instrumental variables in Mendelian randomization studies to examine modifiable causes and consequences of cardiometabolic diseases
  • study long-term effects and safety of cardiometabolic drugs using drug-target Mendelian randomization
  • study genetic, proteomic and phenotypic predictors of cardiovascular disease
  • contribute to international consortia on these topics

For more information, see also:

In collaboration with Novartis Norge AS, we are conducting studies of lipoprotein(a) [Lp(a)] in HUNT, utilizing Lp(a) measurements of >25,000 HUNT3 participants (PIs: Åsvold and Haug).

Projects

Projects

Cardiovascular risk trajectories in women with history of pregnancy complications

In this project, we aimed to utilize uniquely longitudinal HUNT cohort data to gain new knowledge about the associations of common pregnancy complications with future cardiovascular disease (CVD) risk. The project was funded by the Research Council of Norway and conducted in collaboration with Brigham and Women’s Hospital and Harvard School of Public Health, and with the University of Bristol.

We estimated the life-course trajectories of blood pressure from pre-pregnancy to >50 ys of age and identified a long-lasting drop in mean blood pressures following pregnancy. From before first pregnancy to beyond 50 ys of age, women with preeclampsia in their first pregnancy consistently had higher mean measures of adiposity, blood pressure, heart rate, and serum lipids and glucose compared with women with a normotensive first pregnancy. This excess adiposity and blood pressure could explain much of the excess risk of CVD events in women with a history of preeclampsia. However, adding information on pregnancy complications did not substantially improve CVD prediction. We also examined associations of parity with life-course serum lipid levels and CVD risk related to offspring birthweight and preterm delivery.

Using a sibling design, we examined CVD risk factors in young adults born after pregnancy with preeclampsia or gestational hypertension. These offspring had a more adverse cardiovascular risk profile in young adulthood than offspring of normotensive pregnancies. However, their siblings, born after a normotensive pregnancy, had a similar risk profile, suggesting that shared genes or lifestyle may account for the association, rather than an intrauterine effect. We have subsequently followed up the study of potential long-term consequences of intrauterine exposures using intergenerational Mendelian randomization, see HUNT MCE Family Consortium.

We have further contributed to international consortia on genetic determinants of pregnancy-related traits such as placental weight.

Obesity

Using the genetic information in HUNT combined with longitudinal measures of body mass since the 1960s, we and close colleagues at NTNU:

  • examined how genetic predisposition has influenced the changes in body mass during the transition to an obesogenic environment. Our studies have shown that the increase in body mass index during the obesity epidemic was stronger among individuals with higher genetic predisposition to obesity, highlighting the importance of interactions between genetic predisposition and the obesogenic environment in obesity development.
  • study differences in the genetic contribution to childhood and adult obesity, and we utilize these differences to study the differential impact of childhood and adulthood obesity on health in adulthood – see GWAS
  • examine the causal effects of obesity on both chronic and infectious diseases (asthma, lung cancer, psoriasis, eczema, sepsis, chronic kidney disease and mortality 
  • study the causal effects of maternal influences on offspring birthweight and late-life body mass index – see HUNT MCE Family Consortium

Diabetes

Diabetes has been a key component of the HUNT Study since the 1980s. Recent and ongoing work includes studies of:

  • undiagnosed diabetes. In HUNT4 (2017-19), only approximately 1 out of 10 diabetes cases were undiagnosed.
  • novel diabetes subgroups
  • genetic contributions to diabetes from the 1980s until now
  • risk factors for LADA, with observational and Mendelian randomization studies in collaboration with Karolinska Institute